You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 12, 2025

Details for Patent: 10,213,393


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,213,393 protect, and when does it expire?

Patent 10,213,393 protects OSMOLEX ER and is included in one NDA.

Summary for Patent: 10,213,393
Title:Composition and method for treating neurological disease
Abstract: The present disclosure is directed to methods of treating neurological disorders in a patient such as Parkinson's disease, drug-induced extrapyramidal reactions, and/or levodopa-induced dyskinesia comprising administering to the patient once daily in the morning a pharmaceutical composition comprising about 50 mg to about 400 mg of extended-release amantadine or a pharmaceutically acceptable salt thereof.
Inventor(s): Meyer; Glenn A. (Wilmington, NC), Faour; Joaquina (Ciudad Autonoma de Buenos Aires, AR), Pastini; Ana Cristina (Ciudad Autonoma de Buenos Aires, AR), Befumo; Marcelo Fernando (Ciudad Autonoma de Buenos Aires, AR)
Assignee: Osmotica Kereskedelmi es Szolgaltato Korlatolt Feleossegu Tarsasag (Budapest, HU)
Application Number:15/898,143
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,213,393

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the details of United States Patent 10,213,393, focusing on its claims, scope, and the broader patent landscape.

Overview of the Patent

United States Patent 10,213,393, titled "Composition and Method for Treating Neurological Disease," was issued on February 26, 2019. This patent pertains to a specific composition and method designed to treat neurological diseases.

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the core inventions. These claims typically outline the essential elements of the invention that distinguish it from prior art.

  • Claim 1: This claim usually describes the broadest aspect of the invention, such as the composition itself, including the active ingredients and any specific formulations.
  • Claim 2: This might detail a method of using the composition, including dosage, administration routes, and treatment protocols.

Dependent Claims

Dependent claims build upon the independent claims, adding more specific details or limitations. These claims help to narrow down the scope of the invention and provide additional protection.

  • Claim 3: This could specify a particular dosage form, such as a tablet or capsule.
  • Claim 4: This might detail a specific neurological disease that the composition is intended to treat, such as Parkinson's disease or Alzheimer's disease.

Scope of the Patent

The scope of a patent is defined by its claims and is critical in determining what is protected and what is not.

Composition

The patent protects a specific composition designed to treat neurological diseases. This composition likely includes a combination of active ingredients and excipients that are formulated in a particular way to achieve the desired therapeutic effect.

Method of Treatment

The method claims cover the process of using the composition to treat neurological diseases. This includes the dosage regimen, administration route, and any specific treatment protocols.

Patent Landscape

Prior Art

To understand the novelty and non-obviousness of the invention, it is essential to review prior art in the field. The Common Citation Document (CCD) application, provided by the USPTO, can be useful in consolidating prior art citations from multiple patent offices, helping to visualize the global patent landscape for similar inventions[1].

Related Patents

Other patents in the same field can provide insight into the competitive landscape. For example, patents related to controlled release dosage forms or treatments for neurological diseases can indicate how this patent fits into the broader intellectual property landscape[4].

Search Tools and Resources

USPTO Search Tools

The USPTO offers several tools for searching patents, including the Patent Public Search tool, which provides enhanced access to prior art and modern interfaces for searching patents. The Global Dossier service allows users to view the patent family for a specific application, including related applications from participating IP offices[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs can offer training in patent search techniques and maintain local search resources, which can be invaluable for conducting thorough searches related to this patent[1].

Economic and Statistical Analysis

The Patent Claims Research Dataset provided by the USPTO can offer detailed insights into patent claims and scope. This dataset includes information on claims from US patents granted between 1976 and 2014 and US patent applications published between 2001 and 2014. It can help in analyzing trends and measurements of patent scope, which can be relevant for understanding the economic impact of this patent[3].

Legal and Policy Considerations

The legal and policy environment surrounding patents is constantly evolving. For instance, discussions around a potential small claims patent court highlight the ongoing efforts to streamline patent litigation and make it more accessible to smaller entities[5].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of protection.
  • Prior Art: Reviewing prior art using tools like the CCD application helps in assessing the novelty and non-obviousness of the invention.
  • Patent Landscape: Analyzing related patents and using USPTO search tools provides a comprehensive view of the competitive landscape.
  • Economic Impact: Utilizing datasets like the Patent Claims Research Dataset can offer insights into the economic significance of the patent.
  • Legal Considerations: Staying updated on legal and policy changes, such as potential small claims patent courts, is essential for navigating the patent system effectively.

FAQs

Q: What is the main subject of United States Patent 10,213,393?

A: The main subject is a composition and method for treating neurological diseases.

Q: How can I search for prior art related to this patent?

A: You can use the USPTO's Patent Public Search tool and the Common Citation Document (CCD) application to search for prior art.

Q: What resources are available for learning how to conduct a patent search?

A: The USPTO offers a web-based tutorial and handouts, as well as local Patent and Trademark Resource Centers (PTRCs) that provide training in patent search techniques[1].

Q: How does the Patent Claims Research Dataset help in analyzing patents?

A: The dataset provides detailed information on claims from US patents and applications, including claim-level statistics and document-level statistics, which can help in analyzing trends and measurements of patent scope[3].

Q: What is the significance of the Global Dossier service in patent searching?

A: The Global Dossier service allows users to view the patent family for a specific application, including related applications from participating IP offices, and provides access to file histories, classification, and citation data[1].

Sources

  1. USPTO: Search for patents - USPTO. Retrieved from https://www.uspto.gov/patents/search
  2. USA.gov: U.S. Patent and Trademark Office (USPTO) | USAGov. Retrieved from https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO: Patent Claims Research Dataset - USPTO. Retrieved from https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. The FDA Group: Find Consultants - The FDA Group. Retrieved from https://www.thefdagroup.com/find-consultants/50?hs_amp=true
  5. ACUS: U.S. Patent Small Claims Court. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,213,393

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Supernus Pharms OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-001 Feb 16, 2018 DISCN Yes No 10,213,393 ⤷  Try for Free A PROCESS FOR TREATING A PATIENT SUFFERING FROM PARKINSON'S SYNDROME AND IN NEED OF TREATMENT ⤷  Try for Free
Supernus Pharms OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-004 Apr 22, 2020 DISCN Yes No 10,213,393 ⤷  Try for Free A PROCESS FOR TREATING A PATIENT SUFFERING FROM PARKINSON'S SYNDROME AND IN NEED OF TREATMENT ⤷  Try for Free
Supernus Pharms OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-002 Feb 16, 2018 DISCN Yes No 10,213,393 ⤷  Try for Free A PROCESS FOR TREATING A PATIENT SUFFERING FROM PARKINSON'S SYNDROME AND IN NEED OF TREATMENT ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.